Vimarsana
Biggest News Aggregation in the World

Page 2 - Ablative Solutions News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ablative Solutions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ablative Solutions Today - Breaking & Trending Today

Intensified screening for SARS-CoV-2 in 18 emergency departments in the Paris metropolitan area, France (DEPIST-COVID): A cluster-randomized, two-period, crossover trial - Vimarsana News

Intensified screening for SARS-CoV-2 in 18 emergency departments in the Paris metropolitan area, France (DEPIST-COVID): A cluster-randomized, two-period, crossover trial

Judith Leblanc and co-workers report a cluster-randomized trial evaluating intensive screening for SARS-CoV-2 infection in emergency departments.

Source: plos.org
Effect of Noninvasive Airway Management of Comatose Patients With Acute Poisoning - Vimarsana News

Effect of Noninvasive Airway Management of Comatose Patients With Acute Poisoning

This clinical trial compares the efficacy of intubation withholding vs routine practice on clinical outcomes of comatose patients with acute poisoning and a Gla

Should Intravascular Imaging Be Almost Routine in PCI? - Vimarsana News

Should Intravascular Imaging Be Almost Routine in PCI?

Imaging catheters should be part of most coronary stent procedures and probably all complex cases, advocates say. Several new studies strengthen their case.

Parity for OCT, IVUS in Intravascular Imaging-Guided PCI - Vimarsana News

Parity for OCT, IVUS in Intravascular Imaging-Guided PCI

The two types of imaging catheter, as guides for coronary stent targeting and deployment, led to similar clinical outcomes in the OCTIVUS trial. A meta-analysis backed it up.

Ablative Solutions Completes Enrollment in Pivotal Trial of Peregrine Renal Denervation System - Vimarsana News

Ablative Solutions Completes Enrollment in Pivotal Trial of Peregrine Renal Denervation System

April 12, 2023—Ablative Solutions, Inc. announced the completion of patient enrollment in the TARGET BP I study, which is evaluating alcohol-med